The step-down principle in gonadotrophin treatment and the role of GnRH analogues (Q40839250)

24 September 2017

1 reference

title

The step-down principle in gonadotrophin treatment and the role of GnRH analogues (English)

1 reference

24 September 2017

Fauser BC

1

1 reference

PubMed ID

8358893

24 September 2017

Donderwinkel P

series ordinal

2

1 reference

PubMed ID

8358893

24 September 2017

Schoot DC

series ordinal

3

1 reference

24 September 2017

1 June 1993

1 reference

Bailliere's clinical obstetrics and gynaecology

24 September 2017

1 reference

24 September 2017

7

1 reference

24 September 2017

2

1 reference

24 September 2017

309-330

1 reference

Cumulative ovulation rate in human menopausal/human chorionic gonadotropin-treated monkeys: "step-up" versus "step-down" dose regimens

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

The polycystic ovary. III. Steroid biosynthesis in normal and polycystic ovarian tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotropin with and without leuprolide acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

A model for follicular selection and ovulation: lessons from superovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Concentration of oestrone and oestradiol in follicular fluid and ovarian venous blood of women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Luteal dysfunction in ovulation induction: the role of repetitive human chorionic gonadotropin supplementation during the luteal phase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Management of multiple conceptions after gonadotropin-releasing hormone analog/human menopausal gonadotropin/human chorionic gonadotropin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Purified follicle-stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Induction of ovulation in polycystic ovary syndrome with a combination of a luteinizing hormone-releasing hormone analog and exogenous gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Variation in the biologic and biochemical characteristics of human menopausal gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Clinical-pharmacological studies on human menopausal gonadotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Clinical characteristics of ovulation induction with human menopausal gonadotropins with and without leuprolide acetate in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Functional Studies of Aromatase Activity in Human Granulosa Cells from Normal and Polycystic Ovaries*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

LHRH analogues for ovulation induction, with particular reference to polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Polycystic ovary syndrome: a changing perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

FSH and the control of follicular growth

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Ovarian hyperstimulation syndrome: an update review.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

The luteal phase during gonadotropin therapy: effects of two human chorionic gonadotropin regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Etiology of miscarriage in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Paracrine mechanisms involved in granulosa cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

The importance of follicle-stimulating hormone increase for folliculogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Clinical pharmacodynamics of urinary follicle-stimulating hormone and its application for pharmacokinetic simulation program

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Ovulation induction by step-down administration of purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

1 reference

7 January 2021

Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Growth patterns of nondominant ovarian follicles during the normal menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Transvaginal sonography and abnormal ovarian appearance in menstrual cycle disturbances

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

How to discriminate between normal and polycystic ovaries: transvaginal US study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

17 beta-Oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Human menopausal gonadotropins for anovulation and sterility. Results of 7 years of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Hypersecretion of luteinising hormone, infertility, and miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Administration of pure follicle-stimulating hormone during gonadotropin-releasing hormone agonist therapy in patients with clomiphene-resistant polycystic ovarian disease: hormonal evaluations and clinical perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Multiple pregnancies following induction of ovulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Growth patterns of ovarian follicles during induction of ovulation with decreasing doses of human menopausal gonadotropin following presumed selection in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Effects of gonadotropin releasing hormone agonist addition to gonadotropin induction of ovulation in polycystic ovary syndrome patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Growth of the dominant follicle is similar to normal in patients with gonadotrophin-stimulated polycystic ovary syndrome exhibiting monofollicular development during a decremental dose regimen.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Defective Biosynthesis of Ovarian Steroids in the Stein-Leventhal Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Induction of ovulation with human postmenopausal gonadotropin. 3. Effect of varying dosage schedules on estrogen and pregnanediol excretion levels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Pergonal (Menotropins): A Summary of Clinical Experience in the Induction of Ovulation and Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Ovarian hyperstimulation in polycystic ovary syndrome during therapy with leuprolide acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Monitoring of ovulation induction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Hormonal regulation of the growth and steroidogenic function of human granulosa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

The Role of Gonadotropins in the Selection of the Preovulatory Follicle

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

Ovarian responses in macaques to pulsatile infusion of follicle-stimulating hormone (FSH) and luteinizing hormone: increased sensitivity of the maturing follicle to FSH

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980133-6

7 January 2021

10.1016/S0950-3552(05)80133-6

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

8358893